ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 85 filers reported holding ARGENX SE in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $663,701 | +152.3% | 1,350 | +100.0% | 0.02% | +130.0% |
| Q2 2023 | $263,068 | -47.7% | 675 | -50.0% | 0.01% | -50.0% |
| Q1 2023 | $502,983 | +105.3% | 1,350 | -54.4% | 0.02% | +53.8% |
| Q2 2018 | $245,000 | +17.2% | 2,961 | +13.9% | 0.01% | +44.4% |
| Q1 2018 | $209,000 | -87.0% | 2,600 | -89.8% | 0.01% | -89.3% |
| Q4 2017 | $1,605,000 | – | 25,422 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |